Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

1. Weisel, K.
2. Dimopoulos, M.
3. Song, K.W.
4. Moreau, P.
5. Palumbo, A.
6. Belch, A.
7. Schey, S.
8. Sonneveld, P.
9. Sternas, L.
10. Yu, X.
11. Amatya, R.
12. Gibson, C.J.
13. Zaki, M.
14. Jacques, C.
15. San Miguel, J.